Biogaran is a French pharmaceutical laboratory specialized in generic drugs, a subsidiary of Servier and headquartered in Colombes (France). Founded in 1996, it is now the French leader in generic drugs. In 2018, Biogaran generated gross sales of €1.252 billion with 290 million units sold. Internationally, the group is present in Brazil through Pharlab, and in Nigeria with the acquisition of Swipha in 2017, a local generic specialist.
| Website | http://www.biogaran.com |
| Revenue | $5 million |
| Employees | View employees |
| Industry | Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | Mylan Belgium, Teva Pharmaceuticals, Sandoz, Ratiopharm Direct, Actavis Farmacêutica Ltda (Watson Group), Aurobindo Pharma LTD, SUN PHARMA, Amgen, Fresenius Kabi, Boehringer Ingelheim +50 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Biogaran employee's phone or email?
Biogaran Questions
The Biogaran annual revenue was $5 million in 2026.
The NAICS codes for Biogaran are [32541, 32, 325, 3254].
The SIC codes for Biogaran are [2834, 283, 28].
